nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—CYP1A2—Carmustine—malignant glioma	0.0856	0.57	CbGbCtD
Estradiol—CYP3A4—Temozolomide—malignant glioma	0.0647	0.43	CbGbCtD
Estradiol—SLC22A8—choroid plexus—malignant glioma	0.0219	0.127	CbGeAlD
Estradiol—ESRRB—retina—malignant glioma	0.0113	0.0658	CbGeAlD
Estradiol—Hemiparesis—Temozolomide—malignant glioma	0.00993	0.0323	CcSEcCtD
Estradiol—FABP2—embryo—malignant glioma	0.0097	0.0564	CbGeAlD
Estradiol—Leg edema—Temozolomide—malignant glioma	0.00772	0.0251	CcSEcCtD
Estradiol—GPER1—telencephalon—malignant glioma	0.00715	0.0416	CbGeAlD
Estradiol—Pigmentation disorder—Temozolomide—malignant glioma	0.00623	0.0203	CcSEcCtD
Estradiol—Clotting—Temozolomide—malignant glioma	0.00582	0.0189	CcSEcCtD
Estradiol—Disorder sight—Temozolomide—malignant glioma	0.00437	0.0142	CcSEcCtD
Estradiol—Transient ischaemic attack—Temozolomide—malignant glioma	0.00412	0.0134	CcSEcCtD
Estradiol—GPER1—central nervous system—malignant glioma	0.00406	0.0236	CbGeAlD
Estradiol—GPER1—cerebellum—malignant glioma	0.00397	0.0231	CbGeAlD
Estradiol—Haemorrhoids—Temozolomide—malignant glioma	0.00354	0.0115	CcSEcCtD
Estradiol—Deep vein thrombosis—Temozolomide—malignant glioma	0.00342	0.0111	CcSEcCtD
Estradiol—Aphasia—Carmustine—malignant glioma	0.00332	0.0108	CcSEcCtD
Estradiol—Embolism—Temozolomide—malignant glioma	0.00324	0.0105	CcSEcCtD
Estradiol—GPER1—brain—malignant glioma	0.00323	0.0188	CbGeAlD
Estradiol—Cyst—Carmustine—malignant glioma	0.00322	0.0105	CcSEcCtD
Estradiol—Tooth disorder—Temozolomide—malignant glioma	0.00321	0.0104	CcSEcCtD
Estradiol—Aphasia—Temozolomide—malignant glioma	0.00321	0.0104	CcSEcCtD
Estradiol—Thrombosis—Carmustine—malignant glioma	0.00304	0.00989	CcSEcCtD
Estradiol—Influenza-like symptoms—Temozolomide—malignant glioma	0.00291	0.00947	CcSEcCtD
Estradiol—ESR1—blood vessel—malignant glioma	0.00282	0.0164	CbGeAlD
Estradiol—Menorrhagia—Temozolomide—malignant glioma	0.00281	0.00914	CcSEcCtD
Estradiol—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00281	0.00914	CcSEcCtD
Estradiol—SLCO1C1—telencephalon—malignant glioma	0.00281	0.0163	CbGeAlD
Estradiol—Herpes zoster—Temozolomide—malignant glioma	0.00276	0.00898	CcSEcCtD
Estradiol—Otitis media—Temozolomide—malignant glioma	0.00267	0.00869	CcSEcCtD
Estradiol—Coagulopathy—Temozolomide—malignant glioma	0.00267	0.00869	CcSEcCtD
Estradiol—Hyperaesthesia—Temozolomide—malignant glioma	0.00265	0.00862	CcSEcCtD
Estradiol—ESRRA—medulla oblongata—malignant glioma	0.00261	0.0152	CbGeAlD
Estradiol—Rigors—Temozolomide—malignant glioma	0.00255	0.00828	CcSEcCtD
Estradiol—Endocrine disorder—Temozolomide—malignant glioma	0.00251	0.00816	CcSEcCtD
Estradiol—SLCO4A1—retina—malignant glioma	0.00245	0.0142	CbGeAlD
Estradiol—Accidental injury—Carmustine—malignant glioma	0.00243	0.00791	CcSEcCtD
Estradiol—ESRRA—midbrain—malignant glioma	0.00239	0.0139	CbGeAlD
Estradiol—Breast pain—Temozolomide—malignant glioma	0.00238	0.00775	CcSEcCtD
Estradiol—Amenorrhoea—Temozolomide—malignant glioma	0.00237	0.0077	CcSEcCtD
Estradiol—ESRRA—spinal cord—malignant glioma	0.00233	0.0135	CbGeAlD
Estradiol—Drug interaction—Carmustine—malignant glioma	0.00232	0.00754	CcSEcCtD
Estradiol—Viral infection—Temozolomide—malignant glioma	0.0023	0.00749	CcSEcCtD
Estradiol—Herpes simplex—Temozolomide—malignant glioma	0.00226	0.00734	CcSEcCtD
Estradiol—SLCO4A1—telencephalon—malignant glioma	0.00225	0.0131	CbGeAlD
Estradiol—ESR2—brainstem—malignant glioma	0.00225	0.0131	CbGeAlD
Estradiol—Gait disturbance—Carmustine—malignant glioma	0.00221	0.00717	CcSEcCtD
Estradiol—SHBG—brainstem—malignant glioma	0.00219	0.0127	CbGeAlD
Estradiol—Hearing impaired—Temozolomide—malignant glioma	0.00219	0.0071	CcSEcCtD
Estradiol—Neck pain—Carmustine—malignant glioma	0.00218	0.00708	CcSEcCtD
Estradiol—Pulmonary embolism—Carmustine—malignant glioma	0.00215	0.007	CcSEcCtD
Estradiol—Gait disturbance—Temozolomide—malignant glioma	0.00213	0.00693	CcSEcCtD
Estradiol—Musculoskeletal pain—Temozolomide—malignant glioma	0.00211	0.00684	CcSEcCtD
Estradiol—Pulmonary embolism—Temozolomide—malignant glioma	0.00208	0.00676	CcSEcCtD
Estradiol—Vaginal inflammation—Temozolomide—malignant glioma	0.00208	0.00676	CcSEcCtD
Estradiol—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00208	0.00676	CcSEcCtD
Estradiol—Urinary incontinence—Carmustine—malignant glioma	0.00208	0.00676	CcSEcCtD
Estradiol—Candida infection—Carmustine—malignant glioma	0.00206	0.00668	CcSEcCtD
Estradiol—Skin exfoliation—Carmustine—malignant glioma	0.00206	0.00668	CcSEcCtD
Estradiol—Influenza like illness—Temozolomide—malignant glioma	0.00202	0.00657	CcSEcCtD
Estradiol—SLCO1C1—midbrain—malignant glioma	0.00202	0.0117	CbGeAlD
Estradiol—Urinary incontinence—Temozolomide—malignant glioma	0.00201	0.00653	CcSEcCtD
Estradiol—ESR2—telencephalon—malignant glioma	0.002	0.0116	CbGeAlD
Estradiol—Skin exfoliation—Temozolomide—malignant glioma	0.00199	0.00646	CcSEcCtD
Estradiol—Candida infection—Temozolomide—malignant glioma	0.00199	0.00646	CcSEcCtD
Estradiol—SLCO1C1—spinal cord—malignant glioma	0.00197	0.0114	CbGeAlD
Estradiol—SLC22A3—embryo—malignant glioma	0.00197	0.0114	CbGeAlD
Estradiol—Vaginal infection—Temozolomide—malignant glioma	0.00196	0.00638	CcSEcCtD
Estradiol—Neoplasm—Carmustine—malignant glioma	0.00195	0.00633	CcSEcCtD
Estradiol—Gynaecomastia—Carmustine—malignant glioma	0.00193	0.00626	CcSEcCtD
Estradiol—Dry eye—Temozolomide—malignant glioma	0.00192	0.00625	CcSEcCtD
Estradiol—ESRRA—central nervous system—malignant glioma	0.00189	0.011	CbGeAlD
Estradiol—Neoplasm—Temozolomide—malignant glioma	0.00188	0.00611	CcSEcCtD
Estradiol—Abnormal vision—Carmustine—malignant glioma	0.00188	0.0061	CcSEcCtD
Estradiol—ABCC10—telencephalon—malignant glioma	0.00187	0.0109	CbGeAlD
Estradiol—ESRRA—cerebellum—malignant glioma	0.00185	0.0107	CbGeAlD
Estradiol—Abnormal vision—Temozolomide—malignant glioma	0.00181	0.0059	CcSEcCtD
Estradiol—Phlebitis—Carmustine—malignant glioma	0.00181	0.0059	CcSEcCtD
Estradiol—Thrombophlebitis—Carmustine—malignant glioma	0.00181	0.00587	CcSEcCtD
Estradiol—Swelling—Carmustine—malignant glioma	0.00177	0.00576	CcSEcCtD
Estradiol—Ear pain—Temozolomide—malignant glioma	0.00177	0.00575	CcSEcCtD
Estradiol—SLCO4A1—medulla oblongata—malignant glioma	0.00177	0.0103	CbGeAlD
Estradiol—SLCO2B1—telencephalon—malignant glioma	0.00175	0.0102	CbGeAlD
Estradiol—Thrombophlebitis—Temozolomide—malignant glioma	0.00174	0.00567	CcSEcCtD
Estradiol—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00174	0.00564	CcSEcCtD
Estradiol—Gastroenteritis—Temozolomide—malignant glioma	0.0017	0.00554	CcSEcCtD
Estradiol—Injury—Carmustine—malignant glioma	0.0017	0.00553	CcSEcCtD
Estradiol—Deafness—Temozolomide—malignant glioma	0.00169	0.00549	CcSEcCtD
Estradiol—Vascular purpura—Temozolomide—malignant glioma	0.00169	0.00549	CcSEcCtD
Estradiol—ESR1—embryo—malignant glioma	0.00168	0.00977	CbGeAlD
Estradiol—SLC22A1—telencephalon—malignant glioma	0.00167	0.00973	CbGeAlD
Estradiol—Amnesia—Carmustine—malignant glioma	0.00166	0.00541	CcSEcCtD
Estradiol—Nasal congestion—Temozolomide—malignant glioma	0.00166	0.00539	CcSEcCtD
Estradiol—SLCO4A1—midbrain—malignant glioma	0.00162	0.0094	CbGeAlD
Estradiol—Hot flush—Temozolomide—malignant glioma	0.00161	0.00525	CcSEcCtD
Estradiol—SLCO1A2—telencephalon—malignant glioma	0.00161	0.00937	CbGeAlD
Estradiol—Amnesia—Temozolomide—malignant glioma	0.00161	0.00522	CcSEcCtD
Estradiol—Menopausal symptoms—Temozolomide—malignant glioma	0.0016	0.0052	CcSEcCtD
Estradiol—SLCO1C1—central nervous system—malignant glioma	0.0016	0.00928	CbGeAlD
Estradiol—SLCO4A1—spinal cord—malignant glioma	0.00158	0.00917	CbGeAlD
Estradiol—Purpura—Temozolomide—malignant glioma	0.00157	0.00509	CcSEcCtD
Estradiol—ESR1—brainstem—malignant glioma	0.00154	0.00896	CbGeAlD
Estradiol—Face oedema—Carmustine—malignant glioma	0.00151	0.0049	CcSEcCtD
Estradiol—ESRRA—brain—malignant glioma	0.0015	0.00873	CbGeAlD
Estradiol—Affect lability—Temozolomide—malignant glioma	0.00149	0.00483	CcSEcCtD
Estradiol—CYP1B1—telencephalon—malignant glioma	0.00147	0.00855	CbGeAlD
Estradiol—ABCC10—medulla oblongata—malignant glioma	0.00147	0.00854	CbGeAlD
Estradiol—Face oedema—Temozolomide—malignant glioma	0.00146	0.00474	CcSEcCtD
Estradiol—Liver function test abnormal—Carmustine—malignant glioma	0.00144	0.00469	CcSEcCtD
Estradiol—Mood swings—Temozolomide—malignant glioma	0.00143	0.00465	CcSEcCtD
Estradiol—AR—telencephalon—malignant glioma	0.00139	0.0081	CbGeAlD
Estradiol—Dry skin—Temozolomide—malignant glioma	0.00138	0.0045	CcSEcCtD
Estradiol—SLCO2B1—medulla oblongata—malignant glioma	0.00138	0.008	CbGeAlD
Estradiol—ESR1—telencephalon—malignant glioma	0.00137	0.00795	CbGeAlD
Estradiol—Breast disorder—Temozolomide—malignant glioma	0.00136	0.00444	CcSEcCtD
Estradiol—Dysphagia—Carmustine—malignant glioma	0.00135	0.00439	CcSEcCtD
Estradiol—ABCC10—midbrain—malignant glioma	0.00134	0.00781	CbGeAlD
Estradiol—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00133	0.00433	CcSEcCtD
Estradiol—Abdominal distension—Temozolomide—malignant glioma	0.00131	0.00427	CcSEcCtD
Estradiol—ABCC10—spinal cord—malignant glioma	0.00131	0.00762	CbGeAlD
Estradiol—Dysphagia—Temozolomide—malignant glioma	0.00131	0.00424	CcSEcCtD
Estradiol—SLCO4A1—central nervous system—malignant glioma	0.00128	0.00744	CbGeAlD
Estradiol—Sweating increased—Temozolomide—malignant glioma	0.00127	0.00413	CcSEcCtD
Estradiol—SLCO1C1—brain—malignant glioma	0.00127	0.00737	CbGeAlD
Estradiol—SLCO1A2—medulla oblongata—malignant glioma	0.00127	0.00736	CbGeAlD
Estradiol—Bronchitis—Temozolomide—malignant glioma	0.00126	0.00408	CcSEcCtD
Estradiol—SLCO4A1—cerebellum—malignant glioma	0.00125	0.00727	CbGeAlD
Estradiol—SLCO2B1—spinal cord—malignant glioma	0.00123	0.00714	CbGeAlD
Estradiol—Hyperglycaemia—Carmustine—malignant glioma	0.00122	0.00396	CcSEcCtD
Estradiol—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00121	0.00394	CcSEcCtD
Estradiol—Pneumonia—Carmustine—malignant glioma	0.00121	0.00394	CcSEcCtD
Estradiol—Pollakiuria—Temozolomide—malignant glioma	0.00121	0.00392	CcSEcCtD
Estradiol—Depression—Carmustine—malignant glioma	0.0012	0.0039	CcSEcCtD
Estradiol—Photosensitivity reaction—Temozolomide—malignant glioma	0.00119	0.00387	CcSEcCtD
Estradiol—Weight increased—Temozolomide—malignant glioma	0.00119	0.00386	CcSEcCtD
Estradiol—Weight decreased—Temozolomide—malignant glioma	0.00118	0.00384	CcSEcCtD
Estradiol—Neuropathy peripheral—Carmustine—malignant glioma	0.00118	0.00384	CcSEcCtD
Estradiol—Hyperglycaemia—Temozolomide—malignant glioma	0.00118	0.00383	CcSEcCtD
Estradiol—Urinary tract infection—Carmustine—malignant glioma	0.00117	0.0038	CcSEcCtD
Estradiol—Pneumonia—Temozolomide—malignant glioma	0.00117	0.0038	CcSEcCtD
Estradiol—Infestation NOS—Temozolomide—malignant glioma	0.00116	0.00378	CcSEcCtD
Estradiol—Infestation—Temozolomide—malignant glioma	0.00116	0.00378	CcSEcCtD
Estradiol—Depression—Temozolomide—malignant glioma	0.00116	0.00377	CcSEcCtD
Estradiol—SLCO1A2—midbrain—malignant glioma	0.00116	0.00673	CbGeAlD
Estradiol—Neuropathy peripheral—Temozolomide—malignant glioma	0.00114	0.00371	CcSEcCtD
Estradiol—ESR2—central nervous system—malignant glioma	0.00113	0.0066	CbGeAlD
Estradiol—Urinary tract infection—Temozolomide—malignant glioma	0.00113	0.00368	CcSEcCtD
Estradiol—SLCO1A2—spinal cord—malignant glioma	0.00113	0.00657	CbGeAlD
Estradiol—ABCB1—blood vessel—malignant glioma	0.00111	0.00647	CbGeAlD
Estradiol—ESR2—cerebellum—malignant glioma	0.00111	0.00645	CbGeAlD
Estradiol—SHBG—central nervous system—malignant glioma	0.0011	0.00641	CbGeAlD
Estradiol—Hepatobiliary disease—Temozolomide—malignant glioma	0.0011	0.00358	CcSEcCtD
Estradiol—ABCG2—telencephalon—malignant glioma	0.00109	0.00637	CbGeAlD
Estradiol—Sinusitis—Temozolomide—malignant glioma	0.00109	0.00355	CcSEcCtD
Estradiol—Haemoglobin—Carmustine—malignant glioma	0.00109	0.00353	CcSEcCtD
Estradiol—Haemorrhage—Carmustine—malignant glioma	0.00108	0.00351	CcSEcCtD
Estradiol—SHBG—cerebellum—malignant glioma	0.00108	0.00627	CbGeAlD
Estradiol—Hypoaesthesia—Carmustine—malignant glioma	0.00108	0.0035	CcSEcCtD
Estradiol—AOX1—cerebellum—malignant glioma	0.00107	0.00621	CbGeAlD
Estradiol—Oedema peripheral—Carmustine—malignant glioma	0.00106	0.00346	CcSEcCtD
Estradiol—Connective tissue disorder—Carmustine—malignant glioma	0.00106	0.00345	CcSEcCtD
Estradiol—Haemoglobin—Temozolomide—malignant glioma	0.00105	0.00341	CcSEcCtD
Estradiol—Haemorrhage—Temozolomide—malignant glioma	0.00104	0.0034	CcSEcCtD
Estradiol—Hepatitis—Temozolomide—malignant glioma	0.00104	0.0034	CcSEcCtD
Estradiol—Visual impairment—Carmustine—malignant glioma	0.00104	0.00339	CcSEcCtD
Estradiol—Hypoaesthesia—Temozolomide—malignant glioma	0.00104	0.00338	CcSEcCtD
Estradiol—ABCC10—cerebellum—malignant glioma	0.00104	0.00604	CbGeAlD
Estradiol—Pharyngitis—Temozolomide—malignant glioma	0.00104	0.00337	CcSEcCtD
Estradiol—Urinary tract disorder—Temozolomide—malignant glioma	0.00103	0.00335	CcSEcCtD
Estradiol—Oedema peripheral—Temozolomide—malignant glioma	0.00103	0.00335	CcSEcCtD
Estradiol—Connective tissue disorder—Temozolomide—malignant glioma	0.00103	0.00334	CcSEcCtD
Estradiol—Urethral disorder—Temozolomide—malignant glioma	0.00102	0.00333	CcSEcCtD
Estradiol—SLCO4A1—brain—malignant glioma	0.00102	0.00591	CbGeAlD
Estradiol—Eye disorder—Carmustine—malignant glioma	0.00101	0.00328	CcSEcCtD
Estradiol—Visual impairment—Temozolomide—malignant glioma	0.00101	0.00327	CcSEcCtD
Estradiol—Flushing—Carmustine—malignant glioma	0.001	0.00326	CcSEcCtD
Estradiol—SLCO2B1—central nervous system—malignant glioma	0.000995	0.00579	CbGeAlD
Estradiol—Erythema multiforme—Temozolomide—malignant glioma	0.000988	0.00321	CcSEcCtD
Estradiol—Eye disorder—Temozolomide—malignant glioma	0.000976	0.00317	CcSEcCtD
Estradiol—AR—spinal cord—malignant glioma	0.000975	0.00567	CbGeAlD
Estradiol—Tinnitus—Temozolomide—malignant glioma	0.000974	0.00317	CcSEcCtD
Estradiol—SLCO2B1—cerebellum—malignant glioma	0.000973	0.00566	CbGeAlD
Estradiol—Flushing—Temozolomide—malignant glioma	0.000969	0.00315	CcSEcCtD
Estradiol—Cardiac disorder—Temozolomide—malignant glioma	0.000969	0.00315	CcSEcCtD
Estradiol—Alopecia—Carmustine—malignant glioma	0.000955	0.00311	CcSEcCtD
Estradiol—SLC22A1—central nervous system—malignant glioma	0.000951	0.00553	CbGeAlD
Estradiol—Angiopathy—Temozolomide—malignant glioma	0.000948	0.00308	CcSEcCtD
Estradiol—Mental disorder—Carmustine—malignant glioma	0.000947	0.00308	CcSEcCtD
Estradiol—Immune system disorder—Temozolomide—malignant glioma	0.000944	0.00307	CcSEcCtD
Estradiol—Mediastinal disorder—Temozolomide—malignant glioma	0.000941	0.00306	CcSEcCtD
Estradiol—Malnutrition—Carmustine—malignant glioma	0.000941	0.00306	CcSEcCtD
Estradiol—Erythema—Carmustine—malignant glioma	0.000941	0.00306	CcSEcCtD
Estradiol—Chills—Temozolomide—malignant glioma	0.000937	0.00305	CcSEcCtD
Estradiol—Alopecia—Temozolomide—malignant glioma	0.000923	0.003	CcSEcCtD
Estradiol—SLCO1A2—central nervous system—malignant glioma	0.000916	0.00533	CbGeAlD
Estradiol—Mental disorder—Temozolomide—malignant glioma	0.000915	0.00298	CcSEcCtD
Estradiol—Ethinyl Estradiol—CYP2B6—malignant glioma	0.000914	0.417	CrCbGaD
Estradiol—Back pain—Carmustine—malignant glioma	0.00091	0.00296	CcSEcCtD
Estradiol—Malnutrition—Temozolomide—malignant glioma	0.000909	0.00296	CcSEcCtD
Estradiol—Erythema—Temozolomide—malignant glioma	0.000909	0.00296	CcSEcCtD
Estradiol—SLC22A3—central nervous system—malignant glioma	0.000909	0.00529	CbGeAlD
Estradiol—ESR2—brain—malignant glioma	0.0009	0.00524	CbGeAlD
Estradiol—SLCO1A2—cerebellum—malignant glioma	0.000895	0.00521	CbGeAlD
Estradiol—Dysgeusia—Temozolomide—malignant glioma	0.000891	0.00289	CcSEcCtD
Estradiol—Tremor—Carmustine—malignant glioma	0.000882	0.00287	CcSEcCtD
Estradiol—Back pain—Temozolomide—malignant glioma	0.00088	0.00286	CcSEcCtD
Estradiol—SHBG—brain—malignant glioma	0.000875	0.00509	CbGeAlD
Estradiol—SLC22A8—central nervous system—malignant glioma	0.000874	0.00509	CbGeAlD
Estradiol—AOX1—brain—malignant glioma	0.000867	0.00504	CbGeAlD
Estradiol—Agitation—Carmustine—malignant glioma	0.000865	0.00281	CcSEcCtD
Estradiol—ABCG2—medulla oblongata—malignant glioma	0.00086	0.005	CbGeAlD
Estradiol—Tremor—Temozolomide—malignant glioma	0.000852	0.00277	CcSEcCtD
Estradiol—Ill-defined disorder—Temozolomide—malignant glioma	0.000844	0.00274	CcSEcCtD
Estradiol—ABCC10—brain—malignant glioma	0.000844	0.00491	CbGeAlD
Estradiol—Agitation—Temozolomide—malignant glioma	0.000836	0.00272	CcSEcCtD
Estradiol—CYP1B1—central nervous system—malignant glioma	0.000835	0.00486	CbGeAlD
Estradiol—Angioedema—Temozolomide—malignant glioma	0.000831	0.0027	CcSEcCtD
Estradiol—Malaise—Temozolomide—malignant glioma	0.00082	0.00267	CcSEcCtD
Estradiol—Vertigo—Temozolomide—malignant glioma	0.000817	0.00266	CcSEcCtD
Estradiol—CYP1B1—cerebellum—malignant glioma	0.000817	0.00475	CbGeAlD
Estradiol—Hypertension—Carmustine—malignant glioma	0.000812	0.00264	CcSEcCtD
Estradiol—Palpitations—Temozolomide—malignant glioma	0.000804	0.00261	CcSEcCtD
Estradiol—Myalgia—Carmustine—malignant glioma	0.000801	0.0026	CcSEcCtD
Estradiol—Chest pain—Carmustine—malignant glioma	0.000801	0.0026	CcSEcCtD
Estradiol—Anxiety—Carmustine—malignant glioma	0.000798	0.0026	CcSEcCtD
Estradiol—Estrone—CYP2B6—malignant glioma	0.000796	0.363	CrCbGaD
Estradiol—Cough—Temozolomide—malignant glioma	0.000794	0.00258	CcSEcCtD
Estradiol—AR—central nervous system—malignant glioma	0.000791	0.0046	CbGeAlD
Estradiol—SLCO2B1—brain—malignant glioma	0.00079	0.0046	CbGeAlD
Estradiol—ABCG2—midbrain—malignant glioma	0.000786	0.00457	CbGeAlD
Estradiol—Hypertension—Temozolomide—malignant glioma	0.000785	0.00255	CcSEcCtD
Estradiol—ESR1—central nervous system—malignant glioma	0.000777	0.00452	CbGeAlD
Estradiol—Confusional state—Carmustine—malignant glioma	0.000774	0.00252	CcSEcCtD
Estradiol—Arthralgia—Temozolomide—malignant glioma	0.000774	0.00252	CcSEcCtD
Estradiol—Myalgia—Temozolomide—malignant glioma	0.000774	0.00252	CcSEcCtD
Estradiol—Anxiety—Temozolomide—malignant glioma	0.000772	0.00251	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000769	0.0025	CcSEcCtD
Estradiol—Oedema—Carmustine—malignant glioma	0.000768	0.0025	CcSEcCtD
Estradiol—ABCG2—spinal cord—malignant glioma	0.000767	0.00446	CbGeAlD
Estradiol—Discomfort—Temozolomide—malignant glioma	0.000765	0.00249	CcSEcCtD
Estradiol—Infection—Carmustine—malignant glioma	0.000763	0.00248	CcSEcCtD
Estradiol—ESR1—cerebellum—malignant glioma	0.000759	0.00442	CbGeAlD
Estradiol—Dry mouth—Temozolomide—malignant glioma	0.000757	0.00246	CcSEcCtD
Estradiol—SLC22A1—brain—malignant glioma	0.000755	0.00439	CbGeAlD
Estradiol—Tachycardia—Carmustine—malignant glioma	0.00075	0.00244	CcSEcCtD
Estradiol—Confusional state—Temozolomide—malignant glioma	0.000748	0.00243	CcSEcCtD
Estradiol—Oedema—Temozolomide—malignant glioma	0.000742	0.00241	CcSEcCtD
Estradiol—Anaphylactic shock—Temozolomide—malignant glioma	0.000742	0.00241	CcSEcCtD
Estradiol—Infection—Temozolomide—malignant glioma	0.000737	0.0024	CcSEcCtD
Estradiol—Nervous system disorder—Temozolomide—malignant glioma	0.000728	0.00237	CcSEcCtD
Estradiol—SLCO1A2—brain—malignant glioma	0.000727	0.00423	CbGeAlD
Estradiol—ALB—brain—malignant glioma	0.000723	0.0042	CbGeAlD
Estradiol—SLC22A3—brain—malignant glioma	0.000722	0.0042	CbGeAlD
Estradiol—Skin disorder—Temozolomide—malignant glioma	0.000721	0.00234	CcSEcCtD
Estradiol—Hyperhidrosis—Temozolomide—malignant glioma	0.000717	0.00233	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0007	0.00227	CcSEcCtD
Estradiol—Insomnia—Carmustine—malignant glioma	0.000695	0.00226	CcSEcCtD
Estradiol—SLC22A8—brain—malignant glioma	0.000694	0.00404	CbGeAlD
Estradiol—Paraesthesia—Carmustine—malignant glioma	0.00069	0.00224	CcSEcCtD
Estradiol—Dyspnoea—Carmustine—malignant glioma	0.000685	0.00223	CcSEcCtD
Estradiol—Somnolence—Carmustine—malignant glioma	0.000683	0.00222	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000676	0.0022	CcSEcCtD
Estradiol—Insomnia—Temozolomide—malignant glioma	0.000671	0.00218	CcSEcCtD
Estradiol—Decreased appetite—Carmustine—malignant glioma	0.000668	0.00217	CcSEcCtD
Estradiol—Paraesthesia—Temozolomide—malignant glioma	0.000666	0.00217	CcSEcCtD
Estradiol—ABCB1—embryo—malignant glioma	0.000664	0.00386	CbGeAlD
Estradiol—CYP1B1—brain—malignant glioma	0.000663	0.00386	CbGeAlD
Estradiol—Gastrointestinal disorder—Carmustine—malignant glioma	0.000663	0.00216	CcSEcCtD
Estradiol—Dyspnoea—Temozolomide—malignant glioma	0.000662	0.00215	CcSEcCtD
Estradiol—Somnolence—Temozolomide—malignant glioma	0.00066	0.00214	CcSEcCtD
Estradiol—Pain—Carmustine—malignant glioma	0.000657	0.00213	CcSEcCtD
Estradiol—Constipation—Carmustine—malignant glioma	0.000657	0.00213	CcSEcCtD
Estradiol—Dyspepsia—Temozolomide—malignant glioma	0.000653	0.00212	CcSEcCtD
Estradiol—Decreased appetite—Temozolomide—malignant glioma	0.000645	0.0021	CcSEcCtD
Estradiol—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000641	0.00208	CcSEcCtD
Estradiol—Fatigue—Temozolomide—malignant glioma	0.00064	0.00208	CcSEcCtD
Estradiol—Constipation—Temozolomide—malignant glioma	0.000635	0.00206	CcSEcCtD
Estradiol—Pain—Temozolomide—malignant glioma	0.000635	0.00206	CcSEcCtD
Estradiol—Feeling abnormal—Carmustine—malignant glioma	0.000633	0.00206	CcSEcCtD
Estradiol—AR—brain—malignant glioma	0.000628	0.00365	CbGeAlD
Estradiol—Gastrointestinal pain—Carmustine—malignant glioma	0.000628	0.00204	CcSEcCtD
Estradiol—ESR1—brain—malignant glioma	0.000617	0.00359	CbGeAlD
Estradiol—Feeling abnormal—Temozolomide—malignant glioma	0.000612	0.00199	CcSEcCtD
Estradiol—ABCG2—cerebellum—malignant glioma	0.000608	0.00354	CbGeAlD
Estradiol—Abdominal pain—Carmustine—malignant glioma	0.000607	0.00197	CcSEcCtD
Estradiol—Body temperature increased—Carmustine—malignant glioma	0.000607	0.00197	CcSEcCtD
Estradiol—Gastrointestinal pain—Temozolomide—malignant glioma	0.000607	0.00197	CcSEcCtD
Estradiol—CYP1A1—central nervous system—malignant glioma	0.000591	0.00344	CbGeAlD
Estradiol—Urticaria—Temozolomide—malignant glioma	0.00059	0.00192	CcSEcCtD
Estradiol—ABCB1—retina—malignant glioma	0.000587	0.00341	CbGeAlD
Estradiol—Abdominal pain—Temozolomide—malignant glioma	0.000587	0.00191	CcSEcCtD
Estradiol—Body temperature increased—Temozolomide—malignant glioma	0.000587	0.00191	CcSEcCtD
Estradiol—Hypersensitivity—Carmustine—malignant glioma	0.000566	0.00184	CcSEcCtD
Estradiol—Asthenia—Carmustine—malignant glioma	0.000551	0.00179	CcSEcCtD
Estradiol—Hypersensitivity—Temozolomide—malignant glioma	0.000547	0.00178	CcSEcCtD
Estradiol—ABCB1—telencephalon—malignant glioma	0.00054	0.00314	CbGeAlD
Estradiol—Asthenia—Temozolomide—malignant glioma	0.000532	0.00173	CcSEcCtD
Estradiol—Diarrhoea—Carmustine—malignant glioma	0.000525	0.00171	CcSEcCtD
Estradiol—Pruritus—Temozolomide—malignant glioma	0.000525	0.00171	CcSEcCtD
Estradiol—CYP2C8—brain—malignant glioma	0.000508	0.00296	CbGeAlD
Estradiol—Dizziness—Carmustine—malignant glioma	0.000508	0.00165	CcSEcCtD
Estradiol—Diarrhoea—Temozolomide—malignant glioma	0.000508	0.00165	CcSEcCtD
Estradiol—ABCG2—brain—malignant glioma	0.000494	0.00287	CbGeAlD
Estradiol—Dizziness—Temozolomide—malignant glioma	0.000491	0.0016	CcSEcCtD
Estradiol—Vomiting—Carmustine—malignant glioma	0.000488	0.00159	CcSEcCtD
Estradiol—Rash—Carmustine—malignant glioma	0.000484	0.00157	CcSEcCtD
Estradiol—Testosterone—CYP2B6—malignant glioma	0.000484	0.221	CrCbGaD
Estradiol—Dermatitis—Carmustine—malignant glioma	0.000484	0.00157	CcSEcCtD
Estradiol—Headache—Carmustine—malignant glioma	0.000481	0.00156	CcSEcCtD
Estradiol—Vomiting—Temozolomide—malignant glioma	0.000472	0.00153	CcSEcCtD
Estradiol—CYP1A1—brain—malignant glioma	0.000469	0.00273	CbGeAlD
Estradiol—Rash—Temozolomide—malignant glioma	0.000468	0.00152	CcSEcCtD
Estradiol—Dermatitis—Temozolomide—malignant glioma	0.000468	0.00152	CcSEcCtD
Estradiol—Headache—Temozolomide—malignant glioma	0.000465	0.00151	CcSEcCtD
Estradiol—Nausea—Carmustine—malignant glioma	0.000456	0.00148	CcSEcCtD
Estradiol—Nausea—Temozolomide—malignant glioma	0.000441	0.00143	CcSEcCtD
Estradiol—CYP3A4—central nervous system—malignant glioma	0.000433	0.00252	CbGeAlD
Estradiol—ABCB1—medulla oblongata—malignant glioma	0.000424	0.00247	CbGeAlD
Estradiol—ABCB1—midbrain—malignant glioma	0.000388	0.00225	CbGeAlD
Estradiol—ABCB1—spinal cord—malignant glioma	0.000378	0.0022	CbGeAlD
Estradiol—ABCB1—central nervous system—malignant glioma	0.000307	0.00178	CbGeAlD
Estradiol—ABCB1—cerebellum—malignant glioma	0.0003	0.00174	CbGeAlD
Estradiol—ABCB1—brain—malignant glioma	0.000244	0.00142	CbGeAlD
Estradiol—AOX1—Disease—AKT1—malignant glioma	1.45e-05	3.94e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.45e-05	3.94e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS1—malignant glioma	1.44e-05	3.92e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CG—malignant glioma	1.44e-05	3.92e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.44e-05	3.91e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—BCHE—malignant glioma	1.44e-05	3.9e-05	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—AKT1—malignant glioma	1.43e-05	3.9e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GSTP1—malignant glioma	1.43e-05	3.89e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.43e-05	3.89e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PDGFB—malignant glioma	1.43e-05	3.88e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CG—malignant glioma	1.43e-05	3.88e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FGFR1—malignant glioma	1.42e-05	3.86e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—SLC5A5—malignant glioma	1.42e-05	3.86e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HIF1A—malignant glioma	1.4e-05	3.8e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.4e-05	3.8e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CB—malignant glioma	1.4e-05	3.79e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CD—malignant glioma	1.39e-05	3.79e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CAT—malignant glioma	1.39e-05	3.78e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PPARG—malignant glioma	1.39e-05	3.78e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NCOR1—malignant glioma	1.39e-05	3.78e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—malignant glioma	1.38e-05	3.76e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PPARG—malignant glioma	1.38e-05	3.75e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PPARG—malignant glioma	1.38e-05	3.74e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.37e-05	3.74e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CD—malignant glioma	1.37e-05	3.72e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.36e-05	3.7e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MYC—malignant glioma	1.35e-05	3.68e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CAV1—malignant glioma	1.35e-05	3.68e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.35e-05	3.67e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—BCHE—malignant glioma	1.34e-05	3.65e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KDR—malignant glioma	1.34e-05	3.64e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.33e-05	3.62e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CG—malignant glioma	1.33e-05	3.62e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.33e-05	3.6e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—IDH1—malignant glioma	1.32e-05	3.6e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.32e-05	3.6e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTT1—malignant glioma	1.32e-05	3.58e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NCOR1—malignant glioma	1.31e-05	3.57e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—VEGFA—malignant glioma	1.31e-05	3.57e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GSTP1—malignant glioma	1.31e-05	3.56e-05	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.31e-05	3.55e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—GSTP1—malignant glioma	1.3e-05	3.54e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CB—malignant glioma	1.3e-05	3.54e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—malignant glioma	1.29e-05	3.51e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FN1—malignant glioma	1.29e-05	3.5e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—F2—malignant glioma	1.29e-05	3.5e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PPARG—malignant glioma	1.28e-05	3.49e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SPHK1—malignant glioma	1.28e-05	3.48e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CAT—malignant glioma	1.28e-05	3.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—BAD—malignant glioma	1.27e-05	3.46e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CAT—malignant glioma	1.27e-05	3.45e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CD—malignant glioma	1.27e-05	3.45e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NOTCH1—malignant glioma	1.26e-05	3.42e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CD—malignant glioma	1.26e-05	3.42e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.26e-05	3.41e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CD—malignant glioma	1.25e-05	3.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.25e-05	3.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.24e-05	3.38e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CD80—malignant glioma	1.23e-05	3.36e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS1—malignant glioma	1.23e-05	3.35e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—APC—malignant glioma	1.23e-05	3.35e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CG—malignant glioma	1.23e-05	3.35e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.23e-05	3.34e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGF—malignant glioma	1.22e-05	3.31e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—AKT1—malignant glioma	1.21e-05	3.3e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CB—malignant glioma	1.21e-05	3.3e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTPN11—malignant glioma	1.21e-05	3.29e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTEN—malignant glioma	1.21e-05	3.28e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NCOR1—malignant glioma	1.21e-05	3.28e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—malignant glioma	1.2e-05	3.27e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—NCOR1—malignant glioma	1.2e-05	3.26e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CB—malignant glioma	1.19e-05	3.24e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.19e-05	3.23e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—malignant glioma	1.18e-05	3.21e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTP1—malignant glioma	1.17e-05	3.18e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CD—malignant glioma	1.17e-05	3.18e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—BRAF—malignant glioma	1.16e-05	3.15e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—BCHE—malignant glioma	1.15e-05	3.12e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTP1—malignant glioma	1.14e-05	3.11e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CAT—malignant glioma	1.14e-05	3.1e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CAV1—malignant glioma	1.13e-05	3.08e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.13e-05	3.08e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT2—malignant glioma	1.13e-05	3.06e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTEN—malignant glioma	1.13e-05	3.06e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—KRAS—malignant glioma	1.12e-05	3.03e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CAT—malignant glioma	1.11e-05	3.02e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CB—malignant glioma	1.11e-05	3e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CB—malignant glioma	1.1e-05	2.98e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—malignant glioma	1.09e-05	2.98e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CB—malignant glioma	1.09e-05	2.97e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—malignant glioma	1.09e-05	2.95e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—malignant glioma	1.08e-05	2.95e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CD—malignant glioma	1.08e-05	2.94e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.08e-05	2.94e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—malignant glioma	1.08e-05	2.94e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NCOR1—malignant glioma	1.08e-05	2.92e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CAV1—malignant glioma	1.07e-05	2.91e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.07e-05	2.91e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTP1—malignant glioma	1.07e-05	2.9e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—malignant glioma	1.06e-05	2.89e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.06e-05	2.88e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NCOR1—malignant glioma	1.05e-05	2.85e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTEN—malignant glioma	1.05e-05	2.85e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—malignant glioma	1.04e-05	2.83e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CAT—malignant glioma	1.04e-05	2.82e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—FGF2—malignant glioma	1.04e-05	2.82e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.03e-05	2.81e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTEN—malignant glioma	1.03e-05	2.8e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—malignant glioma	1.03e-05	2.79e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.02e-05	2.78e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CB—malignant glioma	1.02e-05	2.77e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTT1—malignant glioma	1.02e-05	2.76e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—malignant glioma	1.01e-05	2.75e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PPARG—malignant glioma	9.97e-06	2.71e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—malignant glioma	9.92e-06	2.7e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CAV1—malignant glioma	9.83e-06	2.67e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NCOR1—malignant glioma	9.81e-06	2.67e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CAV1—malignant glioma	9.77e-06	2.66e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CG—malignant glioma	9.76e-06	2.65e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MDM2—malignant glioma	9.7e-06	2.64e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RAF1—malignant glioma	9.67e-06	2.63e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—malignant glioma	9.57e-06	2.6e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTEN—malignant glioma	9.55e-06	2.6e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS1—malignant glioma	9.52e-06	2.59e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTEN—malignant glioma	9.46e-06	2.57e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTEN—malignant glioma	9.45e-06	2.57e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CB—malignant glioma	9.44e-06	2.57e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PPARG—malignant glioma	9.42e-06	2.56e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—AKT1—malignant glioma	9.39e-06	2.55e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.39e-06	2.55e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.33e-06	2.54e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.25e-06	2.52e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTP1—malignant glioma	9.12e-06	2.48e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CD—malignant glioma	9.08e-06	2.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL8—malignant glioma	9.07e-06	2.47e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CG—malignant glioma	8.95e-06	2.43e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CG—malignant glioma	8.9e-06	2.42e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CAT—malignant glioma	8.88e-06	2.41e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—BCHE—malignant glioma	8.85e-06	2.4e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—AKT1—malignant glioma	8.85e-06	2.4e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTEN—malignant glioma	8.81e-06	2.39e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CAV1—malignant glioma	8.77e-06	2.38e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.74e-06	2.38e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CASP3—malignant glioma	8.68e-06	2.36e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—AKT1—malignant glioma	8.68e-06	2.36e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—malignant glioma	8.67e-06	2.36e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PPARG—malignant glioma	8.64e-06	2.35e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PPARG—malignant glioma	8.59e-06	2.33e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CD—malignant glioma	8.58e-06	2.33e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CAV1—malignant glioma	8.56e-06	2.33e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—malignant glioma	8.51e-06	2.31e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NCOR1—malignant glioma	8.38e-06	2.28e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.38e-06	2.28e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—AKT1—malignant glioma	8.38e-06	2.28e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—malignant glioma	8.21e-06	2.23e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTEN—malignant glioma	8.16e-06	2.22e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CAV1—malignant glioma	8e-06	2.17e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CG—malignant glioma	7.99e-06	2.17e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—malignant glioma	7.94e-06	2.16e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CB—malignant glioma	7.92e-06	2.15e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CD—malignant glioma	7.87e-06	2.14e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—malignant glioma	7.84e-06	2.13e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CD—malignant glioma	7.82e-06	2.13e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CG—malignant glioma	7.8e-06	2.12e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PPARG—malignant glioma	7.71e-06	2.1e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.64e-06	2.08e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PPARG—malignant glioma	7.53e-06	2.05e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CB—malignant glioma	7.48e-06	2.03e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—malignant glioma	7.41e-06	2.01e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—malignant glioma	7.4e-06	2.01e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—VEGFA—malignant glioma	7.37e-06	2e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—malignant glioma	7.3e-06	1.98e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.28e-06	1.98e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—malignant glioma	7.28e-06	1.98e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—AKT1—malignant glioma	7.23e-06	1.97e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTP1—malignant glioma	7.04e-06	1.91e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PPARG—malignant glioma	7.03e-06	1.91e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CD—malignant glioma	7.02e-06	1.91e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—AKT1—malignant glioma	6.95e-06	1.89e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.86e-06	1.86e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CD—malignant glioma	6.85e-06	1.86e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CAT—malignant glioma	6.85e-06	1.86e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTEN—malignant glioma	6.84e-06	1.86e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CAV1—malignant glioma	6.83e-06	1.86e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CB—malignant glioma	6.82e-06	1.85e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—malignant glioma	6.79e-06	1.85e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—malignant glioma	6.78e-06	1.84e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—malignant glioma	6.76e-06	1.84e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—malignant glioma	6.74e-06	1.83e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—malignant glioma	6.68e-06	1.81e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—malignant glioma	6.67e-06	1.81e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—malignant glioma	6.63e-06	1.8e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.53e-06	1.77e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—AKT1—malignant glioma	6.49e-06	1.76e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NCOR1—malignant glioma	6.47e-06	1.76e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTEN—malignant glioma	6.46e-06	1.76e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.4e-06	1.74e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KRAS—malignant glioma	6.27e-06	1.7e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CG—malignant glioma	6.22e-06	1.69e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—malignant glioma	6.21e-06	1.69e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CB—malignant glioma	6.12e-06	1.66e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—malignant glioma	6.07e-06	1.65e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—AKT1—malignant glioma	6.05e-06	1.64e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PPARG—malignant glioma	6.01e-06	1.63e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CB—malignant glioma	5.97e-06	1.62e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—AKT1—malignant glioma	5.94e-06	1.62e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTEN—malignant glioma	5.93e-06	1.61e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—malignant glioma	5.92e-06	1.61e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTEN—malignant glioma	5.89e-06	1.6e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—malignant glioma	5.76e-06	1.56e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.58e-06	1.52e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—malignant glioma	5.57e-06	1.51e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—malignant glioma	5.53e-06	1.5e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—AKT1—malignant glioma	5.5e-06	1.5e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CD—malignant glioma	5.47e-06	1.49e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—AKT1—malignant glioma	5.45e-06	1.48e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—AKT1—malignant glioma	5.45e-06	1.48e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTEN—malignant glioma	5.29e-06	1.44e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CAV1—malignant glioma	5.27e-06	1.43e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTEN—malignant glioma	5.16e-06	1.4e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—AKT1—malignant glioma	5.08e-06	1.38e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—malignant glioma	4.83e-06	1.31e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTEN—malignant glioma	4.82e-06	1.31e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.8e-06	1.31e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CB—malignant glioma	4.77e-06	1.3e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—malignant glioma	4.73e-06	1.28e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—AKT1—malignant glioma	4.7e-06	1.28e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PPARG—malignant glioma	4.64e-06	1.26e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—malignant glioma	4.56e-06	1.24e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.22e-06	1.15e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—malignant glioma	4.18e-06	1.14e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—malignant glioma	4.16e-06	1.13e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTEN—malignant glioma	4.12e-06	1.12e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—AKT1—malignant glioma	3.94e-06	1.07e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.73e-06	1.01e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—AKT1—malignant glioma	3.73e-06	1.01e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.68e-06	1e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—malignant glioma	3.65e-06	9.91e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—malignant glioma	3.64e-06	9.9e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—AKT1—malignant glioma	3.42e-06	9.28e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.4e-06	9.25e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—AKT1—malignant glioma	3.4e-06	9.23e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTEN—malignant glioma	3.18e-06	8.64e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—AKT1—malignant glioma	3.05e-06	8.29e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—AKT1—malignant glioma	2.98e-06	8.09e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.91e-06	7.9e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—AKT1—malignant glioma	2.78e-06	7.55e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—AKT1—malignant glioma	2.38e-06	6.46e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.24e-06	6.1e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—AKT1—malignant glioma	1.83e-06	4.98e-06	CbGpPWpGaD
